Pfizer wants to sell vaccines in India at no profit
The Pfizer vaccine is yet to be registered in India although it had applied months ago
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
COVID-19 vaccines: Is foreign good for India
The decision to allow foreign vaccines in India may not take plug the current shortage
What COVID-19 vaccine side effects might I expect?
In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern
Why the US and its allies are stupid to turn COVID-19 vaccination into a geopolitical power play
The COVID-19 pandemic demands that all nations cooperate to vaccinate the entire global population—a goal that can’t be achieved …
Bharat Biotech COVID-19 vaccine claimed to have 80.6% efficacy
'Shot well tolerated in participants; adverse events balanced between vaccine and placebo arms of the trial'
COVID vaccines: How to make sense of reports on their effectiveness
Real-world trials come with some problems: The target of vaccination, what time it was rolled out and emerging variants
Lateral Thoughts: Waiting for bad news
Adverse reactions are part and parcel of vaccination. We can know about safety of COVID-19 vaccines being used in India only after people receive …
Pfizer withdraws application for Emergency Use Authorisation in India
The company will resubmit application after getting more data
Why other African countries need to guard against South Africa COVID-19 variant
WHO and African Centres for Disease Control to strengthen genomic surveillance capacities
Covaxin effective against UK Strain: What does this mean in absence of efficacy data?
Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts
Vaccine Watch: 5 dead in Serum Institute fire; UAE okays Sputnik
PM likely to be vaccinated in March or April, doctor in Shivamogga dies two days after receiving jab and Israel denies vaccine efficacy fears
The Pfizer vaccine may not be the best choice for frail people, but it’s too early to make firm conclusions
While the deaths of elderly people in Norway are sad, they shouldn’t be cause for alarm. This actually tells us the vaccine is stimulating …
Norway reports deaths related to COVID-19 vaccination
Situation not alarming, only ‘small exception’ affected by Pfizer mRNA vaccine: Medical director of Norwegian Medicines Agency
India readies for COVID-19 vaccination but vexed questions on the solution remain
The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …
COVID-19 immunity: how long does it last?
In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic
Dummy’s guide to how trade rules affect access to COVID-19 vaccines
The WTO is considering whether to temporarily waive certain rules about TRIPS, to allow more countries access to vaccines, drugs needed to …
Delaying the second COVID-19 vaccine dose: A medical expert answers key questions
The uncertainty is around how long the protective effect of the first dose will last without a second shot
DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered
CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached
Pfizer’s COVID-19 vaccine becomes first to get emergency authorisation
UK government gives nod on basis of interim results, vaccine to be made available by next week
COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial
Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation
COVID-19 vaccines: How Pfizer and Moderna’s 95% effective mRNA shots work
Should we expect the pandemic to be over once a vaccine is available for public use? Not exactly. A vaccine will not be perfect, and it takes …
Moderna’s COVID vaccine reports 95% efficacy. It means we might have multiple successful vaccines
It opens the door to the possibility we might have many successful vaccines, and be able to tailor different vaccines to people with different needs
Lateral Thoughts: Waiting for the vaccine?
Vaccination programmes cannot be dealt with outside the purview of public health